04:21 PM EDT, 07/16/2025 (MT Newswires) -- Cedric Francois, Director and Chief Executive Officer, on July 14, 2025, sold 139,365 shares in Apellis Pharmaceuticals ( APLS ) for $2,813,091. Following the Form 4 filing with the SEC, Francois has control over a total of 1,881,755 common shares of the company, with 342,333 shares held directly and 1,539,422 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760225019265/xslF345X05/form4.xml